M
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D94.6 KBMAP Pharmaceuticals, Inc.Jan 29, 5:03 PM ET·0001193125-13-028288
- 8-K22.8 KBMAP Pharmaceuticals, Inc.Oct 4, 11:53 AM ET·0001193125-10-222702
- 8-K54.9 KBMAP Pharmaceuticals, Inc.May 4, 7:46 AM ET·0001193125-10-105424
- 8-K67.6 KBMAP Pharmaceuticals, Inc.Aug 3, 8:06 AM ET·0001193125-09-161571
- 10-Q605.1 KBMAP Pharmaceuticals, Inc.Aug 3, 8:00 AM ET·0001193125-09-161559
- SC 13G/A99.1 KBMAP Pharmaceuticals, Inc.Feb 2, 3:59 PM ET·0001193125-09-016365
- 415.8 KBMAP Pharmaceuticals, Inc.Jul 8, 1:24 PM ET·0001181431-08-042501
- 421.4 KBMAP Pharmaceuticals, Inc.Jul 7, 5:10 PM ET·0001181431-08-042380
- 433.2 KBMAP Pharmaceuticals, Inc.Jul 7, 5:10 PM ET·0001181431-08-042379
- 8-K30.0 KBMAP Pharmaceuticals, Inc.Jun 24, 4:32 PM ET·0001193125-08-139220
Insiders
7- ARMER THOMAS ADirector, Chief Scientific Officer
- Borland ScottSVP, Neurology Franchise
- CHAI CHRISTOPHER YSVP, Chief Financial Officer
- Friedman Charlene ASVP, Gen Counsel & Sec
- GIANAKAKOS ANASTASIOSSVP, Chief Business Officer
- KELLERMAN DONALD JSVP,Clinical Dev & Med Affairs
- NELSON TIMOTHY SDirector, President and CEO
Tickers
No tickers on record
Addresses
business
2400 BAYSHORE PARKWAY, SUITE 200
MOUNTAIN VIEW, CA, 94043
mailing
2400 BAYSHORE PARKWAY, SUITE 200
MOUNTAIN VIEW, CA, 94043